Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Influenza vaccines differentially regulate the interferon response in human dendritic cell subsets.

Athale S, Banchereau R, Thompson-Snipes L, Wang Y, Palucka K, Pascual V, Banchereau J.

Sci Transl Med. 2017 Mar 22;9(382). pii: eaaf9194. doi: 10.1126/scitranslmed.aaf9194.

PMID:
28330867
2.

Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly.

Theeten H, Mathei C, Peeters K, Ogunjimi B, Goossens H, Ieven M, Van Damme P, Cools N.

Viral Immunol. 2016 Apr;29(3):169-75. doi: 10.1089/vim.2015.0071. Epub 2016 Mar 22.

3.

The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza.

DiPiazza A, Richards KA, Knowlden ZA, Nayak JL, Sant AJ.

Front Immunol. 2016 Jan 25;7:10. doi: 10.3389/fimmu.2016.00010. eCollection 2016. Review.

4.

Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.

Cox F, Baart M, Huizingh J, Tolboom J, Dekking L, Goudsmit J, Saeland E, Radošević K.

PLoS One. 2015 Dec 22;10(12):e0145243. doi: 10.1371/journal.pone.0145243. eCollection 2015.

5.

Clinical effectiveness of split-virion versus subunit trivalent influenza vaccines in older adults.

Talbot HK, Nian H, Zhu Y, Chen Q, Williams JV, Griffin MR.

Clin Infect Dis. 2015 Apr 15;60(8):1170-5. doi: 10.1093/cid/civ019. Epub 2015 Feb 18.

6.

Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines.

Sasaki S, Holmes TH, Albrecht RA, García-Sastre A, Dekker CL, He XS, Greenberg HB.

J Infect Dis. 2014 Sep 15;210(6):865-74. doi: 10.1093/infdis/jiu190. Epub 2014 Mar 27.

7.

Vaccine-induced boosting of influenza virus-specific CD4 T cells in younger and aged humans.

Dolfi DV, Mansfield KD, Kurupati RK, Kannan S, Doyle SA, Ertl HC, Schmader KE, Wherry EJ.

PLoS One. 2013 Oct 14;8(10):e77164. doi: 10.1371/journal.pone.0077164. eCollection 2013.

8.

Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.

Moise L, Tassone R, Latimer H, Terry F, Levitz L, Haran JP, Ross TM, Boyle CM, Martin WD, De Groot AS.

Hum Vaccin Immunother. 2013 Oct;9(10):2060-8. doi: 10.4161/hv.26511. Epub 2013 Sep 17.

9.

Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison.

Scheifele DW, McNeil SA, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, Hatchette T, Li Y, Montomoli E, Schneeberg A, Bettinger JA, Halperin SA; PHAC /CIHR Influenza Research Network.

Hum Vaccin Immunother. 2013 Nov;9(11):2460-73. Epub 2013 Jul 9.

10.

CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.

Nayak JL, Fitzgerald TF, Richards KA, Yang H, Treanor JJ, Sant AJ.

J Infect Dis. 2013 Jan 15;207(2):297-305. doi: 10.1093/infdis/jis684. Epub 2012 Nov 12.

11.
12.

The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

McElhaney JE, Zhou X, Talbot HK, Soethout E, Bleackley RC, Granville DJ, Pawelec G.

Vaccine. 2012 Mar 9;30(12):2060-7. doi: 10.1016/j.vaccine.2012.01.015. Epub 2012 Jan 27. Review.

13.

Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates.

Weinfurter JT, Brunner K, Capuano SV 3rd, Li C, Broman KW, Kawaoka Y, Friedrich TC.

PLoS Pathog. 2011 Nov;7(11):e1002381. doi: 10.1371/journal.ppat.1002381. Epub 2011 Nov 10.

14.

Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response.

Wagar LE, Gentleman B, Pircher H, McElhaney JE, Watts TH.

PLoS One. 2011;6(8):e23698. doi: 10.1371/journal.pone.0023698. Epub 2011 Aug 22.

15.

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.

Lamere MW, Moquin A, Lee FE, Misra RS, Blair PJ, Haynes L, Randall TD, Lund FE, Kaminski DA.

J Virol. 2011 May;85(10):5027-35. doi: 10.1128/JVI.00150-11. Epub 2011 Mar 2.

16.

Influenza vaccine responses in older adults.

McElhaney JE.

Ageing Res Rev. 2011 Jul;10(3):379-88. doi: 10.1016/j.arr.2010.10.008. Epub 2010 Nov 3. Review.

17.

CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.

Seidel A, Smith D, Yung E, Aquino L, Srivastava T, Pullarkat V, Spielberger R, Forman SJ, Diamond DJ.

Biol Blood Marrow Transplant. 2011 Apr;17(4):524-33. doi: 10.1016/j.bbmt.2010.04.015. Epub 2010 May 8.

18.

Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.

Tu W, Mao H, Zheng J, Liu Y, Chiu SS, Qin G, Chan PL, Lam KT, Guan J, Zhang L, Guan Y, Yuen KY, Peiris JS, Lau YL.

J Virol. 2010 Jul;84(13):6527-35. doi: 10.1128/JVI.00519-10. Epub 2010 Apr 21.

19.

B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant.

Baer J, Santiago F, Yang H, Wu H, Holden-Wiltse J, Treanor J, Topham DJ.

Vaccine. 2010 Jan 22;28(4):907-15. doi: 10.1016/j.vaccine.2009.11.002. Epub 2009 Nov 21.

Supplemental Content

Support Center